0.28400001 EUR
0
0%
Last update Aug 13, 9:12 AM CEST
Market closed
Day range
0.28400001
0.28400001
Previous close
0.28400001
Open
0.28400001
Access this stock data via API
Subscribe
Northwest Biotherapeutics Inc.
0.28
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 170.5K 111.6K 319.6K 196.9K
Cost of revenue
Gross profit
Operating expense
Research & development 6.3M 6.3M 7.1M 9.0M
Selling general and admin 6.0M 6.4M 8.0M 7.0M
Other operating expenses
Operating income -12.2M -12.6M -14.8M -15.8M
Non operating interest income
Income
Expense 2.2M 1.6M 1.4M 2.1M
Other income expense -8.4M 1.0M -366.5K -6.2M
Pretax income -22.9M -13.1M -16.5M -24.1M
Tax provision
Net income -22.9M -13.1M -16.5M -24.1M
Basic EPS 0.0 0.0 0.0
Diluted EPS 0.0 0.0 0.0
Basic average shares 1.3B 1.2B 1.2B
Diluted average shares 1.3B 1.2B 1.2B
EBITDA -13.1M -13.0M -14.3M -16.0M
Net income from continuing op. -22.9M -13.1M -16.5M -24.1M
Minority interests
Preferred stock dividends 300.8K 477.3K 225.8K 232.7K
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 4 hours 23 minutes

03:36
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).